Manufacturing Considerations for Clinical Uses of Therapies Derived from Stem Cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Manufacturing Considerations for Clinical Uses of Therapies Derived from Stem Cells

Published:2006 Issue: Volume: Page:410-430
ISSN:0076-6879
Container-title:Methods in Enzymology
language:
Short-container-title:

Author:

Weber Darin J.

Publisher

Elsevier

Reference31 articles.

1. Combination Products Regulation. Title 21 US Code of Federal Regulations, Part 3.2(e).

2. Donor Eligibility Regulation. Title 21 US Code of Federal Regulations, Part 1271.45.

3. Exemptions and Alternatives Regulation. Title 21 US Code of Federal Regulations, Part 1271.155.

4. Federal Food, Drug and Cosmetic Act, Title 21, USC §321(g), §201(g).

5. General Biological Product Standards Regulation. Title 21 US Code of Federal Regulations, Part 610.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulatory oversight of cell therapy in China: Government’s efforts in patient access and therapeutic innovation;Pharmacological Research;2020-08

2. Creating a stem cell niche in the inner ear using self-assembling peptide amphiphiles;PLOS ONE;2017-12-28

3. Embryonic Stem Cells;Stem Cells in Regenerative Medicine;2016-03-11

4. Cell Production System Based on Flexible Modular Platform;Stem Cell Manufacturing;2016

5. Good Cell Culture Practice for stem cells and stem-cell-derived models;ALTEX;2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP